Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Great-West Lifeco Inc T.GWO

Alternate Symbol(s):  GWLIF | T.GWO.PR.G | GWLPF | GRWTF | T.GWO.PR.I | T.GWO.PR.L | GRWLF | T.GWO.PR.H | T.GWO.PR.M | T.GWO.PR.N | T.GWO.PR.P | T.GWO.PR.Q | T.GWO.PR.R | T.GWO.PR.S | T.GWO.PR.T | T.GWO.PR.Y

Great-West Lifeco Inc. is an international financial services holding company. The Company has interests in life insurance, health insurance, retirement and investment services, asset management and reinsurance businesses. Its segments include Canada, United States, Europe, and Capital and Risk Solutions. It operates in Canada, the United States and Europe under the brands Canada Life, Empower, and Irish Life. It operates through its subsidiaries, including The Canada Life Assurance Company (Canada Life), and Empower Annuity Insurance Company of America (Empower). Canada Life provides insurance and wealth management products and services in Canada, the United Kingdom, the Isle of Man and Germany, and in Ireland through Irish Life. Empower provides retirement plans.


TSX:GWO - Post by User

Post by Blueswinon May 06, 2022 2:14pm
368 Views
Post# 34662922

Scotiabank Reviews Great West Lifeco's Q1 Maintains Sector

Scotiabank Reviews Great West Lifeco's Q1 Maintains Sector

Scotiabank has kept its Sector Perform rating and $38 target on Great West Lifeco after the insurer reported base EPS of $0.87 (+9% Y/Y) which was 2% above both Scotia estimate and the Street.

Analyst Meny Grauman's 2022 base EPS estimate goes up by 2% to $3.70 to reflect the small beat, while his estimate for 2023 remains relatively unchanged at $4.06 (from $4.07).

During the call GWO emphasized the resiliency of its platform and rejected the notion that Europe is more at risk of recession than North America. Scotia is not convinced of that second point, but acknowledges the lifeco's business mix is quite defensive, especially in Europe. The company continues to integrate its MassMutual acquisition in the US where expense synergies are on track, and is embarking on the integration of the Prudential acquisition, which closed right after quarter end. Management indicated that it is accelerating its investments in US retail wealth, which is a linchpin of its US strategy, but Scotia believes this effort is very long-tailed and not a near-term catalyst for the shares.

"Broadly speaking Great West Life delivered a relatively clean quarter that continued to highlight the defensive nature of this stock. The bottom line is that there was nothing in these numbers that changes our thesis on this name, even as the macro environment becomes more complicated."

<< Previous
Bullboard Posts
Next >>